Workflow
生物医药
icon
Search documents
股票行情快报:中关村(000931)1月22日主力资金净买入308.16万元
Sou Hu Cai Jing· 2026-01-22 13:19
Group 1 - The stock of Zhongguancun (000931) closed at 5.17 yuan on January 22, 2026, with an increase of 1.37% and a turnover rate of 1.68% [1] - The trading volume was 126,400 hands, with a total transaction amount of 65.031 million yuan [1] - On January 22, the net inflow of main funds was 3.0816 million yuan, accounting for 4.74% of the total transaction amount, while retail funds had a net outflow of 4.7124 million yuan, accounting for 7.25% [1] Group 2 - For the first three quarters of 2025, Zhongguancun reported a main operating income of 1.882 billion yuan, a year-on-year decrease of 2.46%, and a net profit attributable to shareholders of 49.4914 million yuan, down 4.14% year-on-year [2] - The third quarter of 2025 saw a single-quarter main operating income of 644 million yuan, a decrease of 1.96% year-on-year, and a net profit attributable to shareholders of 10.6825 million yuan, down 29.9% year-on-year [2] - The company has a debt ratio of 51.09%, with investment income of -1.6826 million yuan and financial expenses of 36.1322 million yuan, while the gross profit margin stands at 59.64% [2] Group 3 - Zhongguancun's main business segments include biopharmaceuticals and health products, elderly medical care, commercial concrete, and other businesses [2] - The biopharmaceutical and health products segment involves the research, manufacturing, and sales of various pharmaceutical forms, including chemical drugs, traditional Chinese medicine, and medical devices [2] - The elderly medical care segment encompasses centralized elderly care services, home care services, health management, and traditional Chinese medical services [2]
昊帆生物:关于开立和注销部分募集资金现金管理专用结算账户的公告
证券日报网讯 1月22日,昊帆生物发布公告称,近日,公司全资子公司淮安昊帆生物医药有限公司开立 了募集资金现金管理专用结算账户。鉴于公司及全资子公司安徽昊帆生物有限公司前期设立的部分募集 资金现金管理专用结算账户中相关理财产品已全部到期赎回,且无后续使用计划,因此根据相关规定, 公司于近日办理完毕上述募集资金现金管理专用结算账户的注销手续。 (编辑 任世碧) ...
*ST生物终止收购湖南慧泽生物51%股权
Zhi Tong Cai Jing· 2026-01-22 13:03
*ST生物(000504)(000504.SZ)公告,公司此前拟收购程泽能、易木林、长沙君合致远企业管理咨询合 伙企业(有限合伙)、长沙市履方医药信息咨询合伙企业(有限合伙)合计持有的湖南慧泽生物医药科技有 限公司51%股权。交易各方对本次重大资产重组交易方案进行了多次协商和谈判,未能最终达成一致。 交易各方一致同意终止筹划本次交易,2026年1月22日公司与交易各方签署了《股权收购意向协议之终 止协议》。 ...
*ST生物终止筹划重大资产重组
Bei Jing Shang Bao· 2026-01-22 12:49
据了解,*ST生物原拟收购程泽能、易木林、长沙君合致远企业管理咨询合伙企业(有限合伙)、长沙 市履方医药信息咨询合伙企业(有限合伙)合计持有的湖南慧泽生物医药科技有限公司51%股权。 *ST生物表示,自筹划重大资产重组事项以来,公司按照相关法律法规要求,积极推进本次重大资产重 组的各项工作。交易各方对本次重大资产重组交易方案进行了多次协商和谈判,未能最终达成一致。为 切实维护公司及全体股东利益,经公司审慎研究,并与交易各方友好协商,交易各方一致同意终止筹划 本次交易。 北京商报讯(记者 丁宁)1月22日晚间,*ST生物(000504)发布公告称,公司于2025年8月12日披露了 《关于筹划重大资产重组暨签署股权收购意向协议的提示性公告》,本次筹划重组事项尚未进入正式实 施阶段,交易各方未达成实质性协议,1月22日公司与交易各方签署了《股权收购意向协议之终止协 议》。 ...
*ST生物(000504.SZ):预计2025年净利润2850万元–3250万元 同比扭亏为盈
Ge Long Hui A P P· 2026-01-22 12:44
格隆汇1月22日丨*ST生物(维权)(000504.SZ)公布,预计2025年归属于上市公司股东的净利润2,850万 元–3,250万元,同比扭亏为盈,扣除非经常性损益后的净利润850万元–1,250万元,同比扭亏为盈,营业 收入38,500万元–42,500万元。 1.报告期公司并购并控股了娄底金弘新材料有限公司,进一步丰富了再生资源业务内容,废旧动力电 池、废钢等资源再生利用回收业务大幅度提升了公司收入水平。2.报告期公司大力拓展主营业务相关衍 生产品的销售,包括生物医药业务相关的美妆产品和保健品销售、环保业务相关的产品销售等,带动了 收入和利润的增长。3.报告期公司通过组织架构精简、人员优化、费用管控等降本增效措施,提升了盈 利能力。4.报告期收到的政府补助同比上年增加。 ...
*ST生物(000504.SZ):终止筹划重大资产重组
Ge Long Hui A P P· 2026-01-22 12:44
格隆汇1月22日丨*ST生物(维权)(000504.SZ)公布,公司于2025年8月12日披露了《关于筹划重大资产 重组暨签署股权收购意向协议的提示性公告》(公告编号:2025-047),公司拟收购程泽能、易木林、 长沙君合致远企业管理咨询合伙企业(有限合伙)、长沙市履方医药信息咨询合伙企业(有限合伙)合 计持有的湖南慧泽生物医药科技有限公司51%股权。 自筹划重大资产重组事项以来,公司按照相关法律法规要求,积极推进本次重大资产重组的各项工作。 交易各方对本次重大资产重组交易方案进行了多次协商和谈判,未能最终达成一致。为切实维护公司及 全体股东利益,经公司审慎研究,并与交易各方友好协商,交易各方一致同意终止筹划本次交易,2026 年1月22日公司与交易各方签署了《股权收购意向协议之终止协议》。 ...
北京今年拟首批投入超15亿元促高精尖产业发展
Zhong Guo Xin Wen Wang· 2026-01-22 12:29
Core Viewpoint - Beijing plans to invest over 1.5 billion yuan in the first batch of high-precision and cutting-edge industry development projects to support innovation and the growth of small and medium-sized enterprises [1][2] Group 1: Investment and Funding - The Beijing Municipal Bureau of Economy and Information Technology aims to release no less than 25 policy support directions and plans to invest over 1.5 billion yuan [1] - The funding will cover key industries such as integrated circuits, biomedicine, material energy, information software, and the digital economy [1] Group 2: Innovation Promotion - Beijing encourages market validation opportunities for innovative products in fields like robotics, integrated circuits, and new materials [1] - Support will be provided for the first trial applications of robotics in various domestic scenarios, including factories, supermarkets, logistics, and agriculture [1] - The initiative includes backing for the demonstration application of advanced strategic materials and commercial aerospace companies to mitigate innovation risks through insurance [1] Group 3: Transformation Support - Beijing will support the construction of pilot testing platforms and production lines, providing up to 30% of the total project investment for key technology implementation [2] - Manufacturing enterprises will receive support for introducing new products using existing production capacities, with a maximum funding of 50 million yuan [2] Group 4: Quality and Efficiency Enhancement - The initiative includes support for service providers and benchmark enterprises to offer transformation solutions for large-scale manufacturing enterprises [2] - Standards for green and low-carbon transformation of industrial production lines and data centers will be proposed [2] - Companies will be encouraged to enhance software development efficiency and intelligence through computing power construction, large model deployment, and data governance [2]
掘金港股IPO,理财公司权益投资火力全开
Bei Jing Shang Bao· 2026-01-22 10:25
北京商报讯(记者 宋亦桐)2026年年初,港股市场迎来新一轮新股上市潮,一批硬科技赛道企业密集登陆港交所,成为资本关注的焦点。在此背景下,理 财公司以基石投资者、锚定投资者身份强势入局,开启了权益投资能力升级的全新阶段。1月22日,北京商报记者注意到,部分理财公司在此轮港股打新中 战绩斐然。工银理财披露的10笔港股IPO投资实现100%正收益胜率,投资标的覆盖半导体、人工智能、生物医药、高端装备等核心赛道。分析人士指出,当 前阶段,理财公司参与港股IPO仍以试点和项目制运作为主,但中长期来看,这一实践有望逐步演进为制度化、产品化、策略化的权益配置路径。 2026年开年不到一个月,壁仞科技、MINIMAX等硬科技企业接连登陆港股IPO,点燃市场热情。港股IPO的火热,为手握重金的理财公司提供了全新的投资 舞台,头部理财公司的布局,也在此次新股潮中收获了丰厚的回报。 据工银理财披露的数据,2025年末至2026年初,港股市场步入新股密集发行期,工银理财锁定10只优质港股IPO项目并完成布局,截至1月16日,10笔投资 全部实现正收益,胜率达到100%,单笔最高涨幅达到165.45%。具体来看,工银理财主要投资港股 ...
深圳国资基金圈定三大重点支持硬科技领域
Di Yi Cai Jing· 2026-01-22 10:20
Core Viewpoint - Shenzhen has launched a "State-owned Capital Fund Matrix Three-Year Action Plan" to focus on supporting hard technology sectors such as semiconductors, integrated circuits, artificial intelligence, and biomedicine [1] Group 1: Fund Matrix and Strategic Focus - The fund matrix is based on the "Shenzhen Municipal State-owned Enterprises Fund Business Management Measures (Trial)" issued on January 1, 2023, and aims to cover the entire lifecycle of enterprises from seed to maturity [1] - This initiative is expected to concentrate state-owned capital on forward-looking strategic emerging industries, enhancing the long-term guiding and amplifying role of state-owned capital in technological innovation investments [1] - The Shenzhen State-owned Assets Supervision and Administration Commission aims to link innovation elements such as technology, talent, and scenarios to empower sci-tech enterprises throughout their lifecycle [1] Group 2: Collaboration and Ecosystem Development - Shenzhen's state-owned enterprises are transitioning from "resource holders" to "ecosystem builders," collaborating with private enterprises to create a virtuous cycle of innovation [3] - The Shenzhen Capital Group has invested 86% of its funds in early-stage and growth-stage companies, nurturing 288 listed companies to date [3] - The Kunpeng Capital sub-fund group has a cumulative investment scale exceeding 100 billion, covering nearly 2,000 projects, establishing a mature operational foundation for collaborative development in the industrial chain [3] Group 3: Investment Strategies and Fund Scale - Shenzhen is promoting "bold capital" and "patient capital" from state-owned enterprises, with over 500 funds created by the end of 2024, totaling over 700 billion, with more than 90% directed towards the "20+8" industries [4] - The Shenzhen Semiconductor and Integrated Circuit Industry Investment Fund was established with an initial scale of 5 billion, focusing on investments in semiconductor equipment, components, chip design, and advanced packaging [4] - The Shenzhen State-owned Assets Supervision and Administration Commission emphasizes the importance of maintaining the function of patient capital and continuously improving fund collaboration, project cultivation, and ecological service mechanisms [4]
新产业:近日收到1项国家知识产权局、2项俄罗斯联邦知识产权局颁发的《发明专利证书》
Mei Ri Jing Ji Xin Wen· 2026-01-22 10:11
(记者 曾健辉) 每经AI快讯,新产业1月22日晚间发布公告称,深圳市新产业生物医学工程股份有限公司于近日收到1 项国家知识产权局、2项俄罗斯联邦知识产权局颁发的《发明专利证书》。专利名称分别为"全血样本中 待测物的免疫学检测方法、磁性微球及磁性微球-蛋白复合物中国专利号""试剂组合以及免离心的全血 中目标免疫抑制剂的检测方法"等。 每经头条(nbdtoutiao)——特朗普强要格陵兰岛,丹麦一养老基金率先清仓美债,美国资产全线下 跌!欧洲手握"金融核按钮",双方会"鱼死网破"吗?专家解读→ ...